 |
|
Non-Vitamin K Oral Anticoagulants Associated Bleeding and Its Antidotes
Thorsten Steiner, Martin Köhrmann, Peter D. Schellinger, Georgios Tsivgoulis
J Stroke. 2018;20(3):292-301. Published online 2018 Sep 30 DOI: https://doi.org/10.5853/jos.2018.02250
|
|
Citations to this article as recorded by
 Ultra-Early Hemostatic Therapy for Acute Intracerebral Hemorrhage: An Updated Review
Michael Fortunato, Galadu Subah, Anish D. Thomas, Bridget Nolan, Monica Mureb, Anaz Uddin, Kiran Upadhyay, Jonathan V. Ogulnick, Nitesh Damodara, Colleen Bond, Chirag D. Gandhi, Stephan A. Mayer, Fawaz Al-Mufti
Cardiology in Review.2024; 32(3): 194. CrossRef Standard operating procedure for idarucizumab reversal of dabigatran anticoagulation in ischemic and hemorrhagic stroke
Senta Frol, Janja Pretnar Oblak, Mišo Šabovič, Pawel Kermer
Journal of Thrombosis and Thrombolysis.2023; 55(3): 506. CrossRef Andexanet Alfa to Reverse the Effect of Factor Xa Inhibitors in Intracranial Hemorrhage
Senta Frol, Janja Pretnar Oblak, Mišo Šabovič, Pawel Kermer
CNS Drugs.2023; 37(6): 477. CrossRef Trends in the incidence and mortality of intracerebral hemorrhage, and the associated risk factors, in Denmark from 2004 to 2017
Tine Glavind Bülow Pedersen, Nicklas Vinter, Morten Schmidt, Lars Frost, Pia Cordsen, Grethe Andersen, Søren Paaske Johnsen
European Journal of Neurology.2022; 29(1): 168. CrossRef Andexanet Alfa for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage: Observational Cohort Study
Sebastian Rauch, Hans-Peter Müller, Jens Dreyhaupt, Albert C. Ludolph, Jan Kassubek, Katharina Althaus
Journal of Clinical Medicine.2022; 11(12): 3399. CrossRef Risk factors associated with intracranial bleeding and neurosurgery in patients with mild traumatic brain injury who are receiving direct oral anticoagulants
Gianni Turcato, Arian Zaboli, Massimo Zannoni, Giorgio Ricci, Elisabetta Zorzi, Laura Ciccariello, Andrea Tenci, Norbert Pfeifer, Antonio Maccagnani, Antonio Bonora
The American Journal of Emergency Medicine.2021; 43: 180. CrossRef Perihematomal Edema and Clinical Outcome in Intracerebral Hemorrhage Related to Different Oral Anticoagulants
Jawed Nawabi, Sarah Elsayed, Andrea Morotti, Anna Speth, Melanie Liu, Helge Kniep, Rosalie McDonough, Gabriel Broocks, Tobias Faizy, Elif Can, Peter B. Sporns, Jens Fiehler, Bernd Hamm, Tobias Penzkofer, Georg Bohner, Frieder Schlunk, Uta Hanning
Journal of Clinical Medicine.2021; 10(11): 2234. CrossRef Safety of direct oral anticoagulants in patients with atrial fibrillation and high risk of stroke (review of literature)
E. I. Baranova, V. A. Ionin, A. A. Katsap, O. S. Kolesnik, E. V. Lebedeva
The Scientific Notes of the Pavlov University.2020; 26(3): 43. CrossRef Reversal Treatment in Oral Anticoagulant-Related Intracerebral Hemorrhage—An Observational Study Based on the Swedish Stroke Register
Trine Apostolaki-Hansson, Teresa Ullberg, Mats Pihlsgård, Bo Norrving, Jesper Petersson
Frontiers in Neurology.2020;[Epub] CrossRef Anticoagulation reversal for intracranial hemorrhage in the era of the direct oral anticoagulants
Micheal Strein, Scott May, Gretchen M. Brophy
Current Opinion in Critical Care.2020; 26(2): 122. CrossRef Andexanet alfa for the reversal of factor Xa inhibitors
J Favresse, M Hardy, MA van Dievoet, AL Sennesael, J Douxfils, CM Samama, O Vornicu, AS Dincq, S Lessire, F Mullier
Expert Opinion on Biological Therapy.2019; 19(5): 387. CrossRef Patients on NOACs in the Emergency Room
Stefan T. Gerner, Hagen B. Huttner
Current Neurology and Neuroscience Reports.2019;[Epub] CrossRef Reversal of oral anticoagulation in patients with acute intracerebral hemorrhage
Joji B. Kuramatsu, Jochen A. Sembill, Hagen B. Huttner
Critical Care.2019;[Epub] CrossRef Cerebral small vessel disease: classification, clinical manifestations, diagnosis, and features of treatment
A. A. Kulesh, V. E. Drobakha, V. V. Shestakov
Neurology, Neuropsychiatry, Psychosomatics.2019; 11(3S): 4. CrossRef
|